Professional Documents
Culture Documents
Patient
Periodontitis Derks 2016, Kordbacheh Changi 2019,
No Yes Karoussis 2003, Ferreira 2006,
history
Roccuzzo 2010, Costa 2012
Kordbacheh Changi 2019,
Bone loss/Age < 0.5 > 0.5 - 1.0 > 1.0
Roos-Jansaker 2006
Prosthesis
Kordbacheh Changi 2019, Serino & Ström 2009,
Cleanability Good Poor fit but No access
Heitz-Mayfield 2012, Katafuchi 2018
supramucosal
restorative
Fit/Design Well-fitting margin Ill-fitting Kordbacheh Changi 2019
Site
Keratinised Adequate Minimal Absence Souza 2016, Ladwein 2015, Roccuzzo 2016
mucosa (≥ 2 mm) (< 2 mm)
This Checklist is taken from: L.J.A. Heitz-Mayfield. Risks for Peri-Implant Diseases.
ITI Treatment Guide, Vol. 13: Chapter 6; Pg 36. Quintessence Publishing: Berlin; 2022.
Aesthetic Risk
Assessment Table
This checklist is used to evaluate preoperative risk assessment for optimal esthetic outcomes during
implant therapy in the esthetic zone.
For further information on how to use this table, please refer to ITI Treatment Guide Vol.10*
Level of risk
Esthetic risk factor
Low Medium High
Restorative status
Virgin Restored
of neighboring teeth
Low-scalloped, Medium-scalloped, High-scalloped,
Gingival phenotype
thick medium-thick thin
Vertical bone height: ≤ 6 mm or oblique sinus floor Vertical bone height: > 6 mm and horizontal sinus floor
Grafting with
Simultaneous praticulated Grafting with
autogenous bone bone substitute Prosthetic loading
implant placement after 3 months
(alone or combined material alone
with a bone substitute
material)
Prosthetic loading
Implant placement Implant placement
after 3 to
after 4 to 8 months after 9 to 12 months
6 months
This Decision Tree is taken from: S. S. Jensen. Guidelines for choosing the surgical
technique and grafting protocol for sinus floor elevation. ITI Treatment Guide, Vol. 5,
Chapter 5: Pg 62. Quintessence Publishing: Berlin; 2011
Treating Peri-Implant Mucositis
and Peri-Implantitis
This flow chart assists decision when treating peri-implant mucositis and peri-implantitis.
EXAMINATION
Assess periodontical status. Assess potential risk factors e. g. smoking habits, diabetes.
Assess patient expectations
Modify potential risk factors as required.
Peri-implant probing
Radiograph Assess prosthesis — Assess patientʼs ability for
Obtain previous records if avaliable access for cleanability self-performed plague control
NON-SURGICAL TREATMENT
SURGICAL TREATMENT
Mucoperiosteal flap. Removal of inflamed granulation tissue. Decontamination of implant surface, e. g. chemical —
hydrogen peroxide, chlorhex idine; mechanical — ultrasonic, titanium brush; laser irradiation — ErYA G.
Adequate flap adaptation. Adequate postoperative care — antiseptics, ± periopenrative systemic antimicrobials.
SUPPORTIVE THERAPY
x
1. socket intact and facial socket wall thickness 1. socket wall intact loading (Type A) (Type B) (Type C)
of at least 1 mm 2. primary stability achievable TYPE I2 Implant placement protocol
2. enough bone available apical and palatal to 3. ideal implant position achievable (Immediate) Immediate Type 1A CD Type 1B CD Type 1C SCV
the socket to provide sufficient primary stability placement
(Type 1)
EVIDENCE BASED DENTISTRY 3. socket position within alveolar bone envelope
(EBD) 4. horizontal defect of at least 2 mm CD (yellow): clinically documented; CID (red): clinically
(at implant shoulder) insufficiently documented (includes loading protocols that are
Patient not documented); CWD (green): clinically well documented;
5. no infection at the site SCV (green): scientifically and clinically validated.
EBD
Loading Protocol 3
Clinician Evidence 1. socket not intact and facial socket wall 1. facial bone wall compromised by
Immediate Early Conventional
thicknes of < 1 mm dehiscence or fenestration restoration/ loading
loading
2. inadequate bone available apical and palatal 2. damage to surrounding soft tissue TYPE II–III2 loading (Type A) (Type B) (Type C)
to the socket to provide sufficient primary 3. primary stability not achievable (4–16 weeks) Implant placement protocol
stability 4. ideal implant position compromised Early Type 2–3A CID Type 2–3B CID Type 2–3C SCV
SAC CLASSIFICATION 3. socket and facial bone wall protruding out 5. infection debrided placement
(Type 2–3)
According to the ITI’s SAC of the bone envelope
Classification immediate 4. infection at the site CD (yellow): clinically documented; CID (red): clinically
placement and loading pro- insufficiently documented (includes loading protocols that are
not documented); CWD (green): clinically well documented;
tocols represent advanced SCV (green): scientifically and clinically validated.
to complex procedures that
may be associated with
Loading Protocol 3
advanced to high overall
Immediate Early Conventional
treatment risk. restoration/ loading
loading
RIDGE PRESERVATION TYPE IV 2
loading (Type A) (Type B) (Type C)
Surgial classification 1. clinical situation incompatible with Type I–III OR (4–6 months*) Implant placement protocol
implant placement FORMAL GRAFT Late Type 4A CD Type 4B SCV Type 4C SCV
S A C *(depending on bone grafting) placement
(Type 4)
Prosthodontic classification
CD (yellow): clinically documented; CID (red): clinically
S A C insufficiently documented (includes loading protocols that are
not documented); CWD (green): clinically well documented;
SCV (green): scientifically and clinically validated.
1
Chen ST, Buser D. Clinical and esthetic outcomes of implants 2
Hämmerle CH, Chen ST, Wilson TG Jr. Consensus statements and recommen- 3
Gallucci GO, Hamilton A, Zhou W, Buser D, Chen S. Check out the learning pathway
placed in postextraction sites. Int J Oral Maxillofac Implants. ded clinical procedures regarding the placement of implants in extraction Clin Oral Implants Res. 2018 Oct:29 Suppl 16: 106–134 on immediate implant placement on
2009; 24 Suppl: 186–217. PMID: 19885446. sockets. Int J Oral Maxillofac Implants. 2004;19 Suppl:26-8. PMID: 15635943 the ITI Academy: visit us at WWW.ITI.ORG
LEGEND YES NO